Strong commercial progress in the first half of 2018 >READ
(WorldNews Health)

Strong commercial progress in the first half of 2018 o 89% growth in the number of treatments o Doubling of recurring revenues1: + 87% vs1H`17 o EUR 0.9M sales: + 15% vs1H`17 o Sales to non-Group customers up 61% o Looking for 4 MEUR funding in the next 6 months Malakoff - 16 July 2018 - THERACLION (Euronext Growth, FR0010120402 - ALTHE), a company specialized in leading-edge medical equipment for echotherapy, announces today its sales for the first semester of 2018, closing on June 30th. David Caumartin, Managing Director of Theraclion, says: "Theraclion continues to expand its installed base of Echopulse equipment and recorded sales to non-Group customers of 3 systems in the first half of...